Nattiv R, Wojcicki JM, Garnett EA, Gupta N, Heyman MB. High-dose infliximab for treatment of pediatric ulcerative colitis: A survey of clinical practice. World J Gastroenterol 2012; 18(11): 1229-1234 [PMID: 22468086 DOI: 10.3748/wjg.v18.i11.1229]
Corresponding Author of This Article
Melvin B Heyman, MD, MPH, Professor, Anita Ow Wing Endowed Chair, Department of Pediatrics, UCSF Benioff Children’s Hospital, 500 Parnassus Ave, MU 4 East, Box 0136, University of California, San Francisco, CA 94143-0136, United States. mheyman@peds.ucsf.edu
Article-Type of This Article
Brief Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/